The borderline resectable and locally advanced pancreatic ductal adenocarcinoma: Definition

被引：17

作者：

Soweid, Assaad M. ^{[1
]}

机构：

[1] Amer Univ Beirut, Med Ctr, Dept Internal Med, Div Gastroenterol, Beirut, Lebanon

来源：

ENDOSCOPIC ULTRASOUND | 2017年 / 6卷

关键词：

ONCOLOGY-GROUP; CANCER; 5-FLUOROURACIL; RADIOTHERAPY; FOLFIRINOX; CHEMOTHERAPY; MANAGEMENT; SURVIVAL;

D O I：

10.4103/eus.eus_66_17

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：S76 / S78

页数：3

共 18 条

[1]

[Anonymous], PANCR AD VER 1

[2] Neoadjuvant Modified (m) FOLFIRINOX for Locally Advanced Unresectable (LAPC) and Borderline Resectable (BRPC) Adenocarcinoma of the Pancreas [J].

Blazer, Marlo ;

Wu, Christina ;

Goldberg, Richard M. ;

Phillips, Gary ;

Schmidt, Carl ;

Muscarella, Peter ;

Wuthrick, Evan ;

Williams, Terrence M. ;

Reardon, Joshua ;

Ellison, E. Christopher ;

Bloomston, Mark ;

Bekaii-Saab, Tanios .

ANNALS OF SURGICAL ONCOLOGY, 2015, 22 (04) :1153-1159

[3] Pretreatment Assessment of Resectable and Borderline Resectable Pancreatic Cancer: Expert Consensus Statement [J].

Callery, Mark P. ;

Chang, Kenneth J. ;

Fishman, Elliot K. ;

Talamonti, Mark S. ;

Traverso, L. William ;

Linehan, David C. .

ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (07) :1727-1733

[4] A randomized Phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern cooperative oncology group study E8282 [J].

Cohen, SJ ;

Dobelbower, R ;

Lipsitz, S ;

Catalano, PJ ;

Sischy, B ;

Smith, TJ ;

Haller, DG .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (05) :1345-1350

[5] FOLFIRINOX in Locally Advanced Pancreatic Cancer: The Massachusetts General Hospital Cancer Center Experience [J].

Faris, Jason E. ;

Blaszkowsky, Lawrence S. ;

McDermott, Shaunagh ;

Guimaraes, Alexander R. ;

Szymonifka, Jackie ;

Huynh, Mai Anh ;

Ferrone, Cristina R. ;

Wargo, Jennifer A. ;

Allen, Jill N. ;

Dias, Lauren E. ;

Kwak, Eunice L. ;

Lillemoe, Keith D. ;

Thayer, Sarah P. ;

Murphy, Janet E. ;

Zhu, Andrew X. ;

Sahani, Dushyant V. ;

Wo, Jennifer Y. ;

Clark, Jeffrey W. ;

Fernandez-del Castillo, Carlos ;

Ryan, David P. ;

Hong, Theodore S. .

ONCOLOGIST, 2013, 18 (05) :543-548

[6] Borderline resectable pancreatic cancer: conceptual evolution and current approach to image-based classification [J].

Gilbert, J. W. ;

Wolpin, B. ;

Clancy, T. ;

Wang, J. ;

Mamon, H. ;

Shinagare, A. B. ;

Jagannathan, J. ;

Rosenthal, M. .

ANNALS OF ONCOLOGY, 2017, 28 (09) :2067-2076

[7] Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib The LAP07 Randomized Clinical Trial [J].

Hammel, Pascal ;

Huguet, Florence ;

van Laethem, Jean-Luc ;

Goldstein, David ;

Glimelius, Bengt ;

Artru, Pascal ;

Borbath, Ivan ;

Bouche, Olivier ;

Shannon, Jenny ;

Andre, Thierry ;

Mineur, Laurent ;

Chibaudel, Benoist ;

Bonnetain, Franck ;

Louvet, Christophe .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (17) :1844-1853

[8]

Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21254, 10.3322/caac.21332, 10.3322/caac.21551, 10.3322/caac.20073, 10.3322/caac.21387, 10.3322/caac.21654, 10.3322/caac.21601]

[9] Borderline resectable pancreatic cancer: Definitions and management [J].

Lopez, Nicole E. ;

Prendergast, Cristina ;

Lowy, Andrew M. .

WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) :10740-10751

[10]

Mahaseth H, 2013, PANCREAS, V42, P1311, DOI 10.1097/MPA.0b013e31829e2006

← 1 2 →